Terms: = Kidney tumors AND SPOP, TEF2, 8405, ENSG00000121067, O43791
19 results:
1. Deregulation of spop in Cancer.
Zhang H; Jin X; Huang H
Cancer Res; 2023 Feb; 83(4):489-499. PubMed ID: 36512624
[TBL] [Abstract] [Full Text] [Related]
2. Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma.
Chen Z; Li Z; Li C; Li B; Wang H; Nong D; Li X; Huang G; Lin J; Li W
BMC Cancer; 2022 Dec; 22(1):1277. PubMed ID: 36474188
[TBL] [Abstract] [Full Text] [Related]
3. Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.
Liu D; Augello MA; Grbesa I; Prandi D; Liu Y; Shoag JE; Karnes RJ; Trock BJ; Klein EA; Den RB; Demichelis F; Davicioni E; Sboner A; Barbieri CE
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998599
[TBL] [Abstract] [Full Text] [Related]
4. Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical
Weidle UH; Nopora A
Cancer Genomics Proteomics; 2021; 18(3 Suppl):349-368. PubMed ID: 33994361
[TBL] [Abstract] [Full Text] [Related]
5. [Speckle-type POZ protein up-regulates c-Jun protein expression and promotes proliferation and invasion of renal carcinoma cells].
Wu L; Yu K; Cue Y; Zhu X; Yang Z; Ma J
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):447-452. PubMed ID: 33849838
[TBL] [Abstract] [Full Text] [Related]
6. Mutated spop E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression.
Shi L; Yan Y; He Y; Yan B; Pan Y; Orme JJ; Zhang J; Xu W; Pang J; Huang H
Cancer Res; 2021 Jul; 81(13):3593-3606. PubMed ID: 33762355
[TBL] [Abstract] [Full Text] [Related]
7. spop promotes ubiquitination and degradation of LATS1 to enhance kidney cancer progression.
Wang L; Lin M; Chu M; Liu Y; Ma J; He Y; Wang ZW
EBioMedicine; 2020 Jun; 56():102795. PubMed ID: 32460168
[TBL] [Abstract] [Full Text] [Related]
8. The diverse roles of spop in prostate cancer and kidney cancer.
Wang Z; Song Y; Ye M; Dai X; Zhu X; Wei W
Nat Rev Urol; 2020 Jun; 17(6):339-350. PubMed ID: 32355326
[TBL] [Abstract] [Full Text] [Related]
9. Structure-Activity Relationship of spop Inhibitors against kidney Cancer.
Dong Z; Wang Z; Guo ZQ; Gong S; Zhang T; Liu J; Luo C; Jiang H; Yang CG
J Med Chem; 2020 May; 63(9):4849-4866. PubMed ID: 32297747
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic value of the spop mutant genomic subclass in prostate cancer.
Shoag J; Liu D; Ma X; Oromendia C; Christos P; Ballman K; Angulo C; Cai PY; Gaffney C; Klein E; Karnes J; Den RB; Liu Y; Davicioni E; Barbieri CE
Urol Oncol; 2020 May; 38(5):418-422. PubMed ID: 32192889
[TBL] [Abstract] [Full Text] [Related]
11. The emerging role of spop protein in tumorigenesis and cancer therapy.
Song Y; Xu Y; Pan C; Yan L; Wang ZW; Zhu X
Mol Cancer; 2020 Jan; 19(1):2. PubMed ID: 31901237
[TBL] [Abstract] [Full Text] [Related]
12. The ubiquitin ligase adaptor spop in cancer.
Cuneo MJ; Mittag T
FEBS J; 2019 Oct; 286(20):3946-3958. PubMed ID: 31495053
[TBL] [Abstract] [Full Text] [Related]
13. The E2F1-miR-520/372/373-spop Axis Modulates Progression of Renal Carcinoma.
Ding M; Lu X; Wang C; Zhao Q; Ge J; Xia Q; Wang J; Zen K; Zhang CY; Zhang C
Cancer Res; 2018 Dec; 78(24):6771-6784. PubMed ID: 30348808
[TBL] [Abstract] [Full Text] [Related]
14. Speckle-type POZ protein as a diagnostic biomarker in renal cell carcinoma.
Chauhan A; Bhattacharyya S; Ojha R; Mandal AK; Singh SK
J Cancer Res Ther; 2018; 14(5):977-982. PubMed ID: 30197334
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma.
Adelaiye-Ogala R; Damayanti NP; Orillion AR; Arisa S; Chintala S; Titus MA; Kao C; Pili R
Cancer Res; 2018 Jun; 78(11):2886-2896. PubMed ID: 29572225
[TBL] [Abstract] [Full Text] [Related]
16. Small-Molecule Targeting of E3 Ligase Adaptor spop in kidney Cancer.
Guo ZQ; Zheng T; Chen B; Luo C; Ouyang S; Gong S; Li J; Mao LL; Lian F; Yang Y; Huang Y; Li L; Lu J; Zhang B; Zhou L; Ding H; Gao Z; Zhou L; Li G; Zhou R; Chen K; Liu J; Wen Y; Gong L; Ke Y; Yang SD; Qiu XB; Zhang N; Ren J; Zhong D; Yang CG; Liu J; Jiang H
Cancer Cell; 2016 Sep; 30(3):474-484. PubMed ID: 27622336
[TBL] [Abstract] [Full Text] [Related]
17. spop promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract] [Full Text] [Related]
18. spop promotes tumorigenesis by acting as a key regulatory hub in kidney cancer.
Li G; Ci W; Karmakar S; Chen K; Dhar R; Fan Z; Guo Z; Zhang J; Ke Y; Wang L; Zhuang M; Hu S; Li X; Zhou L; Li X; Calabrese MF; Watson ER; Prasad SM; Rinker-Schaeffer C; Eggener SE; Stricker T; Tian Y; Schulman BA; Liu J; White KP
Cancer Cell; 2014 Apr; 25(4):455-68. PubMed ID: 24656772
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer.
Liu J; Ghanim M; Xue L; Brown CD; Iossifov I; Angeletti C; Hua S; Nègre N; Ludwig M; Stricker T; Al-Ahmadie HA; Tretiakova M; Camp RL; Perera-Alberto M; Rimm DL; Xu T; Rzhetsky A; White KP
Science; 2009 Feb; 323(5918):1218-22. PubMed ID: 19164706
[TBL] [Abstract] [Full Text] [Related]
